The effect of types I and III interferons on adrenocortical cells and its possible implications for autoimmune Addison's disease

作者: A. Hellesen , K. Edvardsen , L. Breivik , E. S. Husebye , E. Bratland

DOI: 10.1111/CEI.12291

关键词: Adrenocortical carcinomaImmunologyAutoantibodyAddison's diseaseChemokine secretionBiologyAutoimmune thyroiditisHuman leukocyte antigenInterferonAdrenal cortex

摘要: Autoimmune Addison's disease (AAD) is caused by selective destruction of the hormone-producing cells adrenal cortex. As yet, little known about potential role played environmental factors in this process. Type I and/or type III interferons (IFNs) are signature responses to virus infections, and have also been implicated pathogenesis autoimmune endocrine disorders such as 1 diabetes thyroiditis. Transient development AAD exacerbation established or subclinical disease, well induction autoantibodies associated with AAD, reported following therapeutic administration IFNs. We therefore hypothesize that exposure IFNs could render cortex susceptible attack genetically predisposed individuals. In study, we investigated possible immunopathological effects on adrenocortical relation AAD. Both types exerted significant cytotoxicity NCI-H295R carcinoma potentiated IFN-γ-and polyinosine-polycytidylic acid [poly (I : C)]-induced chemokine secretion. Furthermore, observed increased expression human leucocyte antigen (HLA) class molecules up-regulation 21-hydroxylase, primary antigenic target propose these combined serve initiate aggravate an ongoing response against

参考文章(64)
Kouichi OSHIMOTO, Hiroyuki SHIMIZU, Noriyuki SATO, Masatomo MORI, [A case of Addison's disease which became worse during interferon therapy: insulin secretion under hyposmolarity]. Nihon Naibunpi Gakkai zasshi. ,vol. 70, pp. 511- 516 ,(1994) , 10.1507/ENDOCRINE1927.70.5_511
Nagako Akeno, Eric P. Smith, Mihaela Stefan, Amanda K. Huber, Weijia Zhang, Mehdi Keddache, Yaron Tomer, IFN-α Mediates the Development of Autoimmunity both by Direct Tissue Toxicity and through Immune Cell Recruitment Mechanisms The Journal of Immunology. ,vol. 186, pp. 4693- 4706 ,(2011) , 10.4049/JIMMUNOL.1002631
P. S. Ohashi, K. Buerki, H. Hengartner, H. Pircher, B. Odermatt, S. Oehen, Pedro Luis Herrera, R. M. Zinkernagel, P. Aichele, Y. Higuchi, Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-alpha. Journal of Immunology. ,vol. 150, pp. 5185- 5194 ,(1993)
Eirik Bratland, Beate Skinningsrud, Dag E. Undlien, Edna Mozes, Eystein S. Husebye, T cell responses to steroid cytochrome P450 21-hydroxylase in patients with autoimmune primary adrenal insufficiency. The Journal of Clinical Endocrinology and Metabolism. ,vol. 94, pp. 5117- 5124 ,(2009) , 10.1210/JC.2009-1115
Eirik Bratland, Geir Bredholt, Gunnar Mellgren, Per M. Knappskog, Edna Mozes, Eystein S. Husebye, The purification and application of biologically active recombinant steroid cytochrome P450 21-hydroxylase: the major autoantigen in autoimmune Addison's disease. Journal of Autoimmunity. ,vol. 33, pp. 58- 67 ,(2009) , 10.1016/J.JAUT.2009.02.018
N Itoh, T Hanafusa, A Miyazaki, J Miyagawa, K Yamagata, K Yamamoto, M Waguri, A Imagawa, S Tamura, M Inada, Mononuclear cell infiltration and its relation to the expression of major histocompatibility complex antigens and adhesion molecules in pancreas biopsy specimens from newly diagnosed insulin-dependent diabetes mellitus patients. Journal of Clinical Investigation. ,vol. 92, pp. 2313- 2322 ,(1993) , 10.1172/JCI116835
P. Fabris, A. Floreani, F.De Lazzari, C. Betterle, N.A. Greggio, R. Naccarato, M. Chiaramonte, Development of type 1 diabetes mellitus during interferon alfa therapy for chronic HCV hepatitis. The Lancet. ,vol. 340, pp. 548- 548 ,(1992) , 10.1016/0140-6736(92)91744-S
Paul Sheppard, Wayne Kindsvogel, Wenfeng Xu, Katherine Henderson, Stacy Schlutsmeyer, Theodore E. Whitmore, Rolf Kuestner, Ursula Garrigues, Carl Birks, Jenny Roraback, Craig Ostrander, Dennis Dong, Jinu Shin, Scott Presnell, Brian Fox, Betty Haldeman, Emily Cooper, David Taft, Teresa Gilbert, Francis J. Grant, Monica Tackett, William Krivan, Gary McKnight, Chris Clegg, Don Foster, Kevin M. Klucher, IL-28, IL-29 and their class II cytokine receptor IL-28R Nature Immunology. ,vol. 4, pp. 63- 68 ,(2003) , 10.1038/NI873
A. Shimada, J. Morimoto, K. Kodama, R. Suzuki, Y. Oikawa, O. Funae, A. Kasuga, T. Saruta, S. Narumi, Elevated Serum IP-10 Levels Observed in Type 1 Diabetes Diabetes Care. ,vol. 24, pp. 510- 515 ,(2001) , 10.2337/DIACARE.24.3.510
Sae Uno, Akihisa Imagawa, Kenji Saisho, Kohei Okita, Hiromi Iwahashi, Toshiaki Hanafusa, Iichiro Shimomura, Expression of chemokines, CXC chemokine ligand 10 (CXCL10) and CXCR3 in the inflamed islets of patients with recent-onset autoimmune type 1 diabetes Endocrine Journal. ,vol. 57, pp. 991- 996 ,(2010) , 10.1507/ENDOCRJ.K10E-076